Neurescue Announces Appointment of Medtronic Veteran Mette-Marie Harild to Company's Board of Directors Ms. Harild Brings Over 30 Years of Medical Device and Pharmaceutical Industry Experience Neurescue, a clinical-stage medical device company bringing to market the world's first computer-aided balloon catheter for aortic occlusion, today announced that medical device industry veteran Mette-Marie Harild has been appointed to the Neurescue board of directors. Most recently the regional vice president of Medtronic's largest sub-region in Europe, Middle East and Africa (EMEA), Ms. Harild brings significant medical device experience to the team. "I am thrilled to join the board of directors at Neurescue to help advance its next-generation balloon catheter technology in development, which has the potential to save the lives of the millions of people worldwide suffering from cardiac arrest each year," said Mette-Marie Harild. "There has been little innovation in the treatment approach to cardiac arrest over the past several decades, and I am extremely proud to support the Neurescue team as they redefine the current standard of care for patients."